Reuters logo
BRIEF-Immunomedics announces reconstituted board and leadership succession plan
January 9, 2017 / 11:18 AM / 8 months ago

BRIEF-Immunomedics announces reconstituted board and leadership succession plan

Jan 9 (Reuters) - Immunomedics Inc

* Immunomedics announces reconstituted board of directors and leadership succession plan

* Immunomedics Inc - Announces chairman and CEO succession plans

* Immunomedics Inc - Effective June 30, 2017, Jason Aryeh will assume role of chairman of Immunomedics board.

* Immunomedics Inc - David M. Goldenberg, current chairman, will transition his role, effective June 30, 2017

* Immunomedics Inc - Board will immediately initiate a search for a new CEO Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below